Skip to content

Clinical trials

Phase 3 Amyotrophic Lateral Sclerosis trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyotrophic Lateral Sclerosis Phase: Phase 3 Country / region: Netherlands Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20111
20121
20151
20161
20182
20193
20201
20216
20223
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated9
Completed8
Active, not recruiting2
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cytokinetics4
Amylyx Pharmaceuticals Inc.2
Humanitas Mirasole SpA2
Knopp Biosciences2
Orion Corporation, Orion Pharma2
ZevraDenmark2
Alector Inc.1
Alexion Pharmaceuticals, Inc.1
Ferrer Internacional S.A.1
Ionis Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyotrophic Lateral Sclerosis22
Motor Neuron Disease3
Frontotemporal Dementia1
Neurodegenerative Diseases1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.